Myositis-specific autoantibodies: overview and recent developments
暂无分享,去创建一个
B. V. van Engelen | W. V. van Venrooij | G. Hengstman | W. V. Vree Egberts | Gerald J.D. Hengstman | Wilma T.M. Vree Egberts | Walther J. van Venrooij
[1] Koen Vos,et al. How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. , 2002, Arthritis and rheumatism.
[2] B. V. van Engelen,et al. Anti-Jo-1 positive inclusion body myositis with a marked and sustained clinical improvement after oral prednisone , 2001, Journal of neurology, neurosurgery, and psychiatry.
[3] E. Girbal-Neuhauser,et al. The Major Synovial Targets of the Rheumatoid Arthritis-Specific Antifilaggrin Autoantibodies Are Deiminated Forms of the α- and β-Chains of Fibrin1 , 2001, The Journal of Immunology.
[4] Amy E. Cox,et al. The DNA mismatch repair enzyme PMS1 is a myositis-specific autoantigen. , 2001, Arthritis and rheumatism.
[5] D. Isenberg,et al. Autoantibody profiles in the sera of European patients with myositis , 2001, Annals of the rheumatic diseases.
[6] F. Breedveld,et al. Secretion of anti-citrulline-containing peptide antibody by B lymphocytes in rheumatoid arthritis. , 2001, Arthritis and rheumatism.
[7] T. Mimori,et al. Myositis and interstitial lung disease associated with autoantibody to a transfer RNA-related protein Wa. , 2000, The Journal of rheumatology.
[8] Van Venrooij Wj,et al. Autoantibody testing in the evaluation of idiopathic inflammatory myopathies: myositis-specific autoantibodies: are they ready to leave the bench for the bedside? , 2000 .
[9] T. Kveder,et al. Immunoserological aspects of idiopathic inflammatory muscle disease. , 2000, Wiener klinische Wochenschrift.
[10] M. V. van Leeuwen,et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. , 2000, Arthritis and rheumatism.
[11] E. Gromnica-ihle,et al. Clinical and Serological Aspects of Patients with Anti-Jo-1 Antibodies – an Evolving Spectrum of Disease Manifestations , 2000, Clinical Rheumatology.
[12] R. Wada,et al. Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[13] P. Roepstorff,et al. Heterogeneous nuclear ribonucleoproteins C1/C2 identified as autoantigens by biochemical and mass spectrometric methods , 2000, Arthritis research.
[14] R. Rodenburg,et al. Cell death: a trigger of autoimmunity? , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.
[15] B. V. van Engelen,et al. Myositis during long-term interferon-α treatment , 2000, Neurology.
[16] M. Mamula,et al. Molecular mimicry and the role of B lymphocytes in the processing of autoantigens , 2000, Cellular and Molecular Life Sciences CMLS.
[17] E. Girbal-Neuhauser,et al. In the rheumatoid pannus, anti‐filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum , 2000, Clinical and experimental immunology.
[18] P. Anderson,et al. Death, autoantigen modifications, and tolerance , 2000, Arthritis research.
[19] B. V. van Engelen,et al. Autoantibody testing in the evaluation of idiopathic inflammatory myopathies: myositis-specific autoantibodies: are they ready to leave the bench for the bedside? , 2000, Journal of clinical neuromuscular disease.
[20] J. Hazes,et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. , 2000, Arthritis and rheumatism.
[21] B. V. van Engelen,et al. Myositis during long-term interferon-alpha treatment. , 2000, Neurology.
[22] J. Jacobs,et al. The prognostic value of the antiperinuclear factor, anti-citrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis. , 1999, Clinical and experimental rheumatology.
[23] M. Mathews,et al. Inosine and N1-methylinosine within a synthetic oligomer mimicking the anticodon loop of human tRNA(Ala) are major epitopes for anti-PL-12 myositis autoantibodies. , 1999, RNA.
[24] T. Mimori,et al. Anti-KS: identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease. , 1999, Journal of immunology.
[25] D. Reinberg,et al. The Dermatomyositis-Specific Autoantigen Mi2 Is a Component of a Complex Containing Histone Deacetylase and Nucleosome Remodeling Activities , 1998, Cell.
[26] MD G. J. D. Hengstman,et al. Presence of the anti–Jo‐1 autoantibody excludes inclusion body myositis , 1998, Annals of neurology.
[27] B. V. van Engelen,et al. Frequent occurrence of anti-tRNA(His) autoantibodies that recognize a conformational epitope in sera of patients with myositis. , 1998, Arthritis and rheumatism.
[28] P. Anderson,et al. Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens. , 1998, Arthritis and rheumatism.
[29] F. V. D. van den Hoogen,et al. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. , 1998, The Journal of clinical investigation.
[30] I. Hausmanowa-Petrusewicz,et al. Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies. , 1997, Arthritis and rheumatism.
[31] R. Barohn,et al. The therapeutic dilemma of inclusion body myositis , 1997, Neurology.
[32] T. Mimori. Structures targeted by the immune system in myositis. , 1996, Current opinion in rheumatology.
[33] J. Reveille,et al. Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis. , 1996, Arthritis and rheumatism.
[34] Marinos C. Dalakas. Immunopathogenesis of inflammatory myopathies , 1995, Annals of neurology.
[35] I. Targoff,et al. Immune manifestations of inflammatory muscle disease. , 1994, Rheumatic diseases clinics of North America.
[36] I. Targoff,et al. Myositis-associated antigens. Aminoacyl-tRNA synthetases Jo-1, PL-7, PL-12, EJ, and OJ , 1994 .
[37] F. Miller. Myositis-Specific Autoantibodies: Touchstones for Understanding the Inflammatory Myopathies , 1993 .
[38] M. Joffe,et al. Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacy. , 1993, The American journal of medicine.
[39] Charles Pj,et al. The Consensus Workshops for the Detection of Autoantibodies to Intracellular Antigens in Rheumatic Diseases: 1989-1992. , 1992 .
[40] T. Mimori,et al. Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in Japanese patients with inflammatory muscle disease. , 1992, Arthritis and rheumatism.
[41] W. V. van Venrooij,et al. The Consensus Workshops for the Detection of Autoantibodies to Intracellular Antigens in Rheumatic Diseases: 1989-1992. , 1992, Clinical and experimental rheumatology.
[42] M. Dalakas. Polymyositis, dermatomyositis and inclusion-body myositis. , 1991, The New England journal of medicine.
[43] M. Dalakas,et al. A New Approach to the Classification of Idiopathic Inflammatory Myopathy: Myositis‐Specific Autoantibodies Define Useful Homogeneous Patient Groups , 1991, Medicine.
[44] T. Mimori,et al. A novel autoantibody reactive with a 48 kDa tRNA associated protein in patients with scleroderma. , 1991, The Journal of rheumatology.
[45] I. Targoff,et al. Antibody to signal recognition particle in polymyositis. , 1990, Arthritis and rheumatism.
[46] I. Targoff. Autoantibodies to aminoacyl-transfer RNA synthetases for isoleucine and glycine. Two additional synthetases are antigenic in myositis. , 1990, Journal of immunology.
[47] F. Arnett,et al. Anti-KJ: a new antibody associated with the syndrome of polymyositis and interstitial lung disease. , 1989, The Journal of clinical investigation.
[48] T. Mimori,et al. Characterization of human autoantibodies that selectively precipitate the 7SL RNA component of the signal recognition particle. , 1987, Journal of immunology.
[49] G. Blobel,et al. Human autoantibodies reactive with the signal-recognition particle. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[50] M. Mathews,et al. Autoantibodies against alanyl-tRNA synthetase and tRNAAla coexist and are associated with myositis , 1986, The Journal of experimental medicine.
[51] I. Targoff,et al. The association between Mi-2 antibodies and dermatomyositis. , 1985, Arthritis and rheumatism.
[52] F. Arnett,et al. Multiplicity of antibodies in myositis sera. , 1984, Arthritis and rheumatism.
[53] M. Mathews,et al. Anti-threonyl-tRNA synthetase, a second myositis-related autoantibody , 1984, The Journal of experimental medicine.
[54] M. Mathews,et al. Myositis autoantibody inhibits histidyl-tRNA synthetase: a model for autoimmunity , 1983, Nature.
[55] M. Reichlin,et al. Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system. , 1980, Arthritis and rheumatism.